149 related articles for article (PubMed ID: 17575114)
1. Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: a new paradigm for antimetabolite radiosensitizers.
Flanagan SA; Robinson BW; Krokosky CM; Shewach DS
Mol Cancer Ther; 2007 Jun; 6(6):1858-68. PubMed ID: 17575114
[TBL] [Abstract][Full Text] [Related]
2. Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells.
Robinson BW; Im MM; Ljungman M; Praz F; Shewach DS
Cancer Res; 2003 Oct; 63(20):6935-41. PubMed ID: 14583494
[TBL] [Abstract][Full Text] [Related]
3. The role of cell cycle progression in radiosensitization by 2',2'-difluoro-2'-deoxycytidine.
Ostruszka LJ; Shewach DS
Cancer Res; 2000 Nov; 60(21):6080-8. PubMed ID: 11085531
[TBL] [Abstract][Full Text] [Related]
4. Drug metabolism and homologous recombination repair in radiosensitization with gemcitabine.
Im MM; Flanagan SA; Ackroyd JJ; Shewach DS
Radiat Res; 2015 Jan; 183(1):114-23. PubMed ID: 25564718
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization by gemcitabine in p53 wild-type and mutant MCF-7 breast carcinoma cell lines.
Robinson BW; Shewach DS
Clin Cancer Res; 2001 Aug; 7(8):2581-9. PubMed ID: 11489842
[TBL] [Abstract][Full Text] [Related]
6. The role of apoptosis in 2',2'-difluoro-2'-deoxycytidine (gemcitabine)-mediated radiosensitization.
Lawrence TS; Davis MA; Hough A; Rehemtulla A
Clin Cancer Res; 2001 Feb; 7(2):314-9. PubMed ID: 11234886
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of 2',2'-difluoro-2'-deoxycytidine and radiation sensitization of human colon carcinoma cells.
Shewach DS; Hahn TM; Chang E; Hertel LW; Lawrence TS
Cancer Res; 1994 Jun; 54(12):3218-23. PubMed ID: 8205542
[TBL] [Abstract][Full Text] [Related]
8. MLH1 deficiency enhances radiosensitization with 5-fluorodeoxyuridine by increasing DNA mismatches.
Flanagan SA; Krokosky CM; Mannava S; Nikiforov MA; Shewach DS
Mol Pharmacol; 2008 Sep; 74(3):863-71. PubMed ID: 18535288
[TBL] [Abstract][Full Text] [Related]
9. Late DNA Damage Mediated by Homologous Recombination Repair Results in Radiosensitization with Gemcitabine.
Im MM; Flanagan SA; Ackroyd JJ; Knapp B; Kramer A; Shewach DS
Radiat Res; 2016 Nov; 186(5):466-477. PubMed ID: 27740890
[TBL] [Abstract][Full Text] [Related]
10. The role of p53 in gemcitabine-mediated cytotoxicity and radiosensitization.
Chen M; Hough AM; Lawrence TS
Cancer Chemother Pharmacol; 2000; 45(5):369-74. PubMed ID: 10803919
[TBL] [Abstract][Full Text] [Related]
11. Differential radiosensitization in DNA mismatch repair-proficient and -deficient human colon cancer xenografts with 5-iodo-2-pyrimidinone-2'-deoxyribose.
Seo Y; Yan T; Schupp JE; Colussi V; Taylor KL; Kinsella TJ
Clin Cancer Res; 2004 Nov; 10(22):7520-8. PubMed ID: 15569982
[TBL] [Abstract][Full Text] [Related]
12. Involvement of p53 in gemcitabine mediated cytotoxicity and radiosensitivity in breast cancer cell lines.
Salem SD; Abou-Tarboush FM; Saeed NM; Al-Qadasi WD; Farah MA; Al-Buhairi M; Al-Harbi N; Alhazza I; Alsbeih G
Gene; 2012 May; 498(2):300-7. PubMed ID: 22353361
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine.
Lawrence TS; Chang EY; Hahn TM; Hertel LW; Shewach DS
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):867-72. PubMed ID: 8598364
[TBL] [Abstract][Full Text] [Related]
14. Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2',2'-difluoro-2'-deoxycytidine (Gemcitabine).
Lawrence TS; Chang EY; Hahn TM; Shewach DS
Clin Cancer Res; 1997 May; 3(5):777-82. PubMed ID: 9815749
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine).
Fields MT; Eisbruch A; Normolle D; Orfali A; Davis MA; Pu AT; Lawrence TS
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):785-91. PubMed ID: 10837965
[TBL] [Abstract][Full Text] [Related]
16. The role of DNA synthesis inhibition in the cytotoxicity of 2',2'-difluoro-2'-deoxycytidine.
Ostruszka LJ; Shewach DS
Cancer Chemother Pharmacol; 2003 Oct; 52(4):325-32. PubMed ID: 12811514
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro.
Latz D; Fleckenstein K; Eble M; Blatter J; Wannenmacher M; Weber KJ
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):875-82. PubMed ID: 9652852
[TBL] [Abstract][Full Text] [Related]
18. Mismatch repair proficiency is not required for radioenhancement by gemcitabine.
van Bree C; Rodermond HM; de Vos J; Haveman J; Franken NA
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1504-9. PubMed ID: 15925456
[TBL] [Abstract][Full Text] [Related]
19. Short hairpin RNA suppression of thymidylate synthase produces DNA mismatches and results in excellent radiosensitization.
Flanagan SA; Cooper KS; Mannava S; Nikiforov MA; Shewach DS
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e613-20. PubMed ID: 22867891
[TBL] [Abstract][Full Text] [Related]
20. Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine.
Morgan MA; Parsels LA; Parsels JD; Mesiwala AK; Maybaum J; Lawrence TS
Cancer Res; 2005 Aug; 65(15):6835-42. PubMed ID: 16061666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
